Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Mylan Selling Generic Lipitor in Europe

By Drug Discovery Trends Editor | May 11, 2012

PITTSBURGH (AP) – Mylan Inc. said May 11 that it is selling a low-cost generic version of the cholesterol drug Lipitor in five European countries.


Mylan said it is selling its generic version in the U.K., Ireland, France, Belgium and the Netherlands. The company is marketing its version of Lipitor, or atorvastatin, in strengths of 10 milligrams, 20 milligrams, 40 milligrams, and 80 milligrams. It said sales of Lipitor in those countries totaled $1.6 billion in 2011.


Pfizer Inc.’s Lipitor has been the biggest-selling drug in the world, with annual sales of as much as $13 billion. U.S. patent protection on the drug ended on Nov. 30.


Watson Pharmaceuticals Inc. makes the authorized generic version in the U.S., and India’s Ranbaxy Laboratories Ltd. is selling the only other approved version of the drug. Mylan and other generic drug companies will be allowed to sell their own versions of Lipitor in the United States starting in June.


Source: The Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE